mdlinx mdlinx
Internal Medicine Articles on MDLinx Top Read Articles
of 2012
Print

Follow-up of rheumatic carditis treated with steroids
Cardiology in the Young, 05/24/2012

Herdy GVH et al. – Many critically ill patients who complied with secondary prophylaxis were left with minor injuries, whereas those who neglected it or abandoned it had serious sequelae. The rate of abandonment and loss to follow–up was very high. Many cases (49%) were re–hospitalised because of carditis recurrence.

Methods
  • This is a retrospective analysis of the outcome of 242 patients with severe rheumatic carditis after discharge from two public hospitals in Niteroi, Brazil.
  • The authors followed up 118 patients for 4 years or more, with an average of 7.7 years.
  • They were treated with antibiotics to accomplish bacterial eradication and either intravenous methylprednisolone – 40 cases – or oral prednisone – 78 patients – to treat carditis.
  • They were followed up in outpatient clinic.

Results
  • Cardiac failure was categorised as classes III and IV according to the New York Heart Association classification.
  • In the intravenous corticosteroid group, 21 cases (52.5%) had isolated mitral valve regurgitation, 12 (30%) had mitral plus aortic involvement, and seven (17.5%) had aortic lesion only. In the oral prednisone group, 45 (58%) had mitral valve regurgitation only, 27 (34%) had mitral plus aortic involvement, and six (8%) had aortic lesion only.
  • A total of 28 children were in their first disease attack, of whom 19 (68%) had a rupture of chordae tendineae.
  • A total of 58 patients (49%) sustained recurrence of carditis because of neglected secondary prophylaxis.
  • In all, 19 cases (16%) underwent cardiac surgery – valve replacement or valvuloplasty.
  • In 33% of the cases, the outcome was favourable – asymptomatic at follow–up.
  • The overall mortality rate was 6.8%.

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close